Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Colorectal Cancer, Systemic Therapy

Axel Grothey

MD

🏢West Cancer Center and Research Institute🌐USA

Director, GI Cancer Research

100
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Axel Grothey is an internationally recognized GI medical oncologist who led pivotal trials in metastatic colorectal cancer including the CORRECT trial of regorafenib and the IDEA collaboration on adjuvant oxaliplatin duration. His work has shaped standard chemotherapy backbones used in CRLM conversion and perioperative therapy. He is a frequent NCCN guideline author.

Share:

🧪Research Fields 研究领域

metastatic colorectal cancer
FOLFOX FOLFIRI
regorafenib TAS-102
adjuvant IDEA trial
colorectal liver metastases chemo

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Axel Grothey 的研究动态

Follow Axel Grothey's research updates

留下邮箱,当我们发布与 Axel Grothey(West Cancer Center and Research Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment